Connect with us

Technology

Evolve Announces Estimated Annual Distributions for Certain Evolve Funds

Published

on

TORONTO, Nov. 29, 2024 /CNW/ – Evolve Funds Group Inc. (“Evolve”) announces the estimated special year end cash income and non-cash notional reinvested income and capital gains distribution per unit (the “Distributions”) for certain Funds (the “Evolve Funds”) for the 2024 tax year.

These estimates are for the annual cash income and non-cash capital gains and income distributions. Non-cash capital gains and income distributions are typically reinvested in additional units of the respective Funds at the year-end, and do not include estimates of ongoing monthly or quarterly cash distribution amounts. The additional units will be immediately consolidated with the previously outstanding units such that the number of outstanding units following the distribution will equal the number of units outstanding prior to the distribution. The reinvestment and immediate consolidation of additional units will result in an increase in the adjusted cost base of units outstanding.

Evolve’s estimates of cash income and non-cash capital gain and income distributions are for information purposes only, to aid with year-end tax and investment planning. These estimates are based on both preliminary and forward-looking information. Actual distributions may differ significantly from the estimates and some of the Funds may pay distributions above or below these estimated ranges, and Funds not currently expected to pay could be required to do so. These estimates are not intended to be used as tax advice. Because each investor’s tax situation is unique, a qualified tax advisor should be consulted.

Evolve expects to announce the final annual cash and reinvested distribution amounts on or about December 31, 2024 for all Evolve Funds with record date of December 31, 2024. The actual taxable amounts of cash and reinvested distributions for 2024, including the tax characteristics of the distributions, will be reported to brokers (through CDS Clearing and Depository Services Inc. or “CDS”) in early 2025.

The estimates are as of October 31, 2024 and could change due to events that occur between the date of these estimates and the date of the Funds’ taxation year end of December 31, 2024 for the High Interest Savings Account Fund, US High Interest Savings Account Fund, Premium Cash Management Fund and US Premium Cash Management Fund and of December 15, 2024 for all other Evolve Funds, and due to a number of factors.  These events and factors may include the following: 

The full measurement period is not captured by these estimates.Portfolio trading and market movements over the next several weeks.Estimates are indicated on a per-share basis. Changes in the number of shares outstanding can have a significant impact on these estimates.These estimates do not reflect all required tax adjustments. Certain tax adjustments are based on market value at a point in time and, therefore, cannot be estimated. Actual distribution amounts will be affected by all required tax adjustments and may be substantially different from these estimates.The period for the Funds’ taxation year may not correspond with the Funds’ fiscal year. This misalignment can have an impact on the amounts distributed and their tax characteristics.

To estimate the dollar value of a distribution for a Fund, multiply the Fund’s total per-share distribution estimate by the number of shares owned.

Evolve Funds

Ticker

Estimated
Reinvested
Income
Distribution
Per Unit

Estimated
Reinvested
Capital Gains
Distribution
Per Unit

Estimated
Cash
Income
Distribution
Per Unit

Currency

Evolve Canadian Aggregate Bond Enhanced Yield Fund

AGG

$0.00000

$0.00000

$0.00000

CAD

Evolve Artificial Intelligence Fund

ARTI

$0.00000

$0.00000

$0.00000

CAD

Evolve Canadian Banks and Lifecos Enhanced Yield Index Fund

BANK

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Materials & Mining Enhanced Yield Index ETF

BASE

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Materials & Mining Enhanced Yield Index ETF

BASE.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Enhanced Yield Bond Fund

BOND

$0.00000

$0.00000

$0.00000

CAD

Evolve Enhanced Yield Bond Fund

BOND.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Enhanced Yield Bond Fund

BOND.U

$0.00000

$0.00000

$0.00000

USD

Evolve US Banks Enhanced Yield Fund

CALL

$0.00000

$0.00000

$0.00000

CAD

Evolve US Banks Enhanced Yield Fund

CALL.B

$0.00000

$0.00000

$0.00000

CAD

Evolve US Banks Enhanced Yield Fund

CALL.U

$0.00000

$0.00000

$0.00000

USD

Evolve Automobile Innovation Index Fund

CARS

$0.00000

$0.00000

$0.08115

CAD

Evolve Automobile Innovation Index Fund

CARS.B

$0.00000

$0.00000

$0.10611

CAD

Evolve Automobile Innovation Index Fund

CARS.U

$0.00000

$0.00000

$0.04753

USD

Evolve Cyber Security Index Fund

CYBR

$0.00000

$0.00000

$0.00000

CAD

Evolve Cyber Security Index Fund

CYBR.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Cyber Security Index Fund

CYBR.U

$0.00000

$0.00000

$0.00000

USD

Evolve Cloud Computing Index Fund

DATA

$0.00000

$0.00000

$0.00000

CAD

Evolve Cloud Computing Index Fund

DATA.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Active Canadian Preferred Share Fund

DIVS

$0.00000

$0.00000

$0.10005

CAD

Evolve Active Global Fixed Income Fund

EARN

$0.00000

$0.00000

$0.33135

CAD

Evolve Bitcoin ETF

EBIT

$0.00000

$0.00000

$0.00000

CAD

Evolve Bitcoin ETF

EBIT.U

$0.00000

$0.00000

$0.00000

USD

Evolve European Banks Enhanced Yield ETF

EBNK

$0.00000

$0.00000

$0.00000

CAD

Evolve European Banks Enhanced Yield ETF

EBNK.B

$0.00000

$0.00000

$0.00000

CAD

Evolve European Banks Enhanced Yield ETF

EBNK.U

$0.00000

$0.00000

$0.00000

USD

Evolve Innovation Index Fund

EDGE

$0.00000

$0.00000

$0.16109

CAD

Evolve Innovation Index Fund

EDGE.U

$0.00000

$0.00000

$0.08822

USD

Evolve S&P 500® Enhanced Yield Fund

ESPX

$0.00000

$0.00000

$0.00000

CAD

Evolve S&P 500® Enhanced Yield Fund

ESPX.B

$0.00000

$0.00000

$0.00000

CAD

Evolve S&P 500® Enhanced Yield Fund

ESPX.U

$0.00000

$0.00000

$0.00000

USD

Evolve Cryptocurrencies ETF

ETC

$0.00000

$0.00000

$0.00583

CAD

Evolve Cryptocurrencies ETF

ETC.U

$0.00000

$0.00000

$0.00886

USD

Evolve Ether ETF

ETHR

$0.00000

$0.00000

$0.00000

CAD

Evolve Ether ETF

ETHR.U

$0.00000

$0.00000

$0.00000

USD

Evolve S&P/TSX 60 Enhanced Yield Fund

ETSX

$0.00000

$0.00000

$0.00000

CAD

Evolve Active Core Fixed Income Fund

FIXD

$0.00000

$0.00000

$0.00000

CAD

Evolve E-Gaming Index ETF

HERO

$0.00000

$0.00000

$0.00000

CAD

High Interest Savings Account Fund

HISA

$0.01589

$0.00000

$0.01478

CAD

US High Interest Savings Account Fund

HISU.U

$0.11793

$0.00000

$0.03880

USD

Evolve Future Leadership Fund

LEAD

$0.00000

$0.00000

$0.00000

CAD

Evolve Future Leadership Fund

LEAD.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Future Leadership Fund

LEAD.U

$0.00000

$0.00000

$0.00000

USD

Evolve Global Healthcare Enhanced Yield Fund

LIFE

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Healthcare Enhanced Yield Fund

LIFE.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Healthcare Enhanced Yield Fund

LIFE.U

$0.00000

$0.00000

$0.00000

USD

Premium Cash Management Fund

MCAD

$0.00000

$0.00000

$0.04199

CAD

US Premium Cash Management Fund

MUSD.U

$0.00000

$3.15032

$0.03844

USD

Evolve NASDAQ Technology Index Fund

QQQT

$0.00000

$1.19006

$0.00000

CAD

Evolve NASDAQ Technology Index Fund

QQQT.B

$0.00000

$0.61190

$0.00000

CAD

Evolve NASDAQ Technology Index Fund

QQQT.U

$0.00000

$0.00000

$0.00000

USD

Evolve NASDAQ Technology Enhanced Yield Index Fund

QQQY

$0.00000

$0.00000

$0.00000

CAD

Evolve FANGMA Index ETF

TECH

$0.00000

$0.46186

$0.00000

CAD

Evolve FANGMA Index ETF

TECH.B

$0.00000

$0.72065

$0.00000

CAD

Evolve FANGMA Index ETF

TECH.U

$0.00000

$0.00000

$0.00000

USD

Evolve Canadian Utilities Enhanced Yield Index Fund

UTES

$0.00000

$0.00000

$0.00000

CAD

Distributions for the Funds will vary from period to period.  For further information regarding the Distributions, please visit www.evolveetfs.com

Commissions, management fees and expenses all may be associated with exchange traded funds (ETFs). ETFs are not guaranteed, their values change frequently and past performance may not be repeated. There are risks involved with investing in ETFs. Please read the prospectus for a complete description of risks relevant to ETFs. Investors may incur customary brokerage commissions in buying or selling ETF units. Please read the prospectus before investing.

Certain statements contained in this news release constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to a future outlook and anticipated distributions, events or results and may include statements regarding future financial performance. In some cases, forward-looking information can be identified by terms such as “may”, “will”, “should”, “expect”, “anticipate”, “believe”, “intend” or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Evolve undertakes no obligation to update publicly or otherwise revise any forward-looking statement whether as a result of new information, future events or other such factors which affect this information, except as required by law.

About Evolve Funds Group Inc.

With over $7.5 billion in assets under management, Evolve is one of Canada’s fastest growing ETF providers since launching its first ETF in September 2017. Evolve specializes in bringing innovative ETFs to Canadian investors. Evolve’s suite of ETFs provide investors with access to: (i) index-based income strategies; (ii) long term investment themes; and (iii) some of the world’s leading investment managers. Established by a team of industry veterans with a proven track record of success, Evolve creates investment products that make a difference.  For more information, please visit www.evolveetfs.com

Join us on social media: Twitter | LinkedIn | Facebook | Youtube

The S&P 500® Index and the S&P/TSX 60 Index are each a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”), and has been licensed for use by the Evolve Funds. S&P® and S&P 500® are trademarks of S&P Global, Inc. or its affiliates (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”). It is not possible to invest directly in an index. The Evolve Funds are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, any of their respective affiliates (collectively, “S&P Dow Jones Indices”). S&P Dow Jones Indices does not make any representation or warranty, express or implied, to the owners of the Evolve Funds or any member of the public regarding the advisability of investing in securities generally or in the Evolve Funds particularly or the ability of the S&P 500® Index and the S&P/TSX 60 Index to track general market performance.  Past performance of an index is not an indication or guarantee of future results. S&P Dow Jones Indices’ only relationship to the Evolve Funds with respect to the S&P 500® Index and the S&P/TSX 60 Index is the licensing of the Indexes and certain trademarks, service marks and/or trade names of S&P Dow Jones Indices and/or its licensors.  The S&P 500® Index and the S&P/TSX 60 Index are determined, composed and calculated by S&P Dow Jones Indices without regard to the Evolve Funds.  S&P Dow Jpones Indices have no obligation to take the needs of the Evolve Funds or the owners of the Evolve Funds into consideration in determining, composing or calculating the S&P 500® Index and the S&P/TSX 60 Index. S&P Dow Jones Indices has no obligation or liability in connection with the administration, marketing or trading of the Evolve Funds. There is no assurance that investment products based on the S&P 500® Index or the S&P/TSX 60 Index will accurately track index performance or provide positive investment returns.  S&P Dow Jones Indices LLC is not an “investment adviser, commodity trading advisory, commodity pool operator, broker dealer, fiduciary, promoter” (as defined in the Investment Company Act of 1940, as amended), “expert” as enumerated within 15 U.S.C. s. 77k(a) or tax advisor.  Inclusion of a security, commodity, crypto currency or other asset within an index is not a recommendation by S&P Dow Jones Indices to buy, sell, or hold such security, commodity, crypto currency or other asset, nor is it considered to be investment advice or commodity trading advice.  

S&P DOW JONES INDICES DOES NOT GUARANTEE THE ADEQUACY, ACCURACY, TIMELINESS AND/OR THE COMPLETENESS OF THE S&P 500® INDEX AND THE S&P/TSX 60 INDEX OR ANY DATA RELATED THERETO OR ANY COMMUNICATION, INCLUDING BUT NOT LIMITED TO, ORAL OR WRITTEN COMMUNICATION (INCLUDING ELECTRONIC COMMUNICATIONS) WITH RESPECT THERETO.  S&P DOW JONES INDICES SHALL NOT BE SUBJECT TO ANY DAMAGES OR LIABILITY FOR ANY ERRORS, OMISSIONS, OR DELAYS THEREIN.  S&P DOW JONES INDICES MAKES NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE OR AS TO RESULTS TO BE OBTAINED BY THE EVOLVE FUNDS, THE OWNERS OF THE EVOLVE FUNDS, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE S&P 500® INDEX AND THE S&P/TSX 60 INDEX OR WITH RESPECT TO ANY DATA RELATED THERETO.  WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT WHATSOEVER SHALL S&P DOW JONES INDICES BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS, TRADING LOSSES, LOST TIME OR GOODWILL, EVEN IF THEY HAVE BEEN ADVISED OF THE POSSIBLITY OF SUCH DAMAGES, WHETHER IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE.  S&P DOW JONES INDICES HAS NOT REVIEWED, PREPARED AND/OR CERTIFIED ANY PORTION OF, NOR DOES S&P DOW JONES INDICES HAVE ANY CONTROL OVER, THE LICENSEE PRODUCT REGISTRATION STATEMENT, PROSPECTUS OR OTHER OFFERING MATERIALS. THERE ARE NO THIRD-PARTY BENEFICIARIES OF ANY AGREEMENTS OR ARRANGEMENTS BETWEEN S&P DOW JONES INDICES AND THE EVOLVE FUNDS OTHER THAN THE LICENSORS OF S&P DOW JONES INDICES.

Nasdaq®, Nasdaq-100®, Nasdaq-100 Index®, Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted™ Index are trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by Evolve ETFs. The Product(s) have not been passed on by the Corporations as to their legality or suitability. The Product(s) are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S).

SOURCE Evolve ETFs

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Argo Corporation Reports Third Quarter 2024 Financial Results

Published

on

By

TORONTO, Nov. 29, 2024 /CNW/ – Argo Corporation (TSXV: ARGH), (OTCQX: ARGHF) (“Argo” or the “Company”), a new venture delivering the first-ever vertically and publicly integrated city transit system, announced today its financial results for the quarter ended September 30, 2024 (“Q3 2024”). During the third quarter of 2024, Argo deployed its smart transit system with its first paying customers and made significant progress in restructuring prior initiatives in its publicly traded entity. 

Argo Highlights

Argo School: The Company successfully deployed its smart transit solution to a series of private schools in the Greater Toronto Area, providing end-to-end student transportation operations. Argo’s innovative technology delivers access to more flexibility and real-time tracking of students and vehicles, with unprecedented safety, reliability, and transparency for families and schools alike. The Company plans to continue to expand this solution to other private and public schools throughout Canada and abroad.Argo City: Argo’s public transit solution is the first to integrate custom software with vehicular hardware to create a network of intelligently routed vehicles that augment public transit systems with on-demand, door-to-door service. Argo City aims to reduce private car usage and increase ridership of existing public transit systems through partnership with cities, transit agencies, and governments. The Company expects to announce its first city partners in the coming months.R&D Investment: The Company’s quarterly R&D investment spend for Q3 2024 increased by 401% year-over-year. This investment reflects a significant focus on developing the Company’s proprietary vertically and publicly integrated city transit system, with significant progress in software and hardware functionality to enable seamless and reliable school and city deployments, putting people in control of their mobility.

Restructuring Updates

Vehicle Subscription: $8.5M in liabilities have been reclassified in Q3 2024 as held for sale as a result of wholly owned subsidiaries Steer EV Canada Inc. filing an assignment into bankruptcy under the Bankruptcy and Insolvency Act in Canada and Steer Holdings LLC, making a General Assignment for the Benefit of Creditors, pursuant to California law. The Company anticipates these liabilities will be removed in the coming quarters upon completing these legal processes, aligning with its restructuring efforts announced in the May 23, 2024, press release.Disputed Office Lease: Argo filed a statement of claim regarding a disputed office lease with landlord 8174709 Canada Inc. and the Company’s former CEO. The disputed lease represents $3.6M in liabilities and payables on the Company’s balance sheet.Sale of Financial Assets: The Company continues to engage in active sales processes for intellectual property and financial assets associated with the last venture in its publicly traded entity. In Q3 2024, the Company completed the sale of 14,200 shares of preferred stock in the capital of Westbrook Global Inc., receiving a cash payment of $750K as consideration.

FoodsUp Updates

Argo maintains a 59.95% non-controlling ownership interest in FoodsUp Inc. (“FoodsUp”), one of Canada’s leading restaurant supply platforms. In Q3 2024, FoodsUp had revenues of $28.7M, representing a 10% increase over Q2 2024 and a 61% yearly increase in quarterly revenues from Q3 2023.

The Company remains committed to implementing a transaction structure, the effect of which would be to provide the shareholders of Argo with the net proceeds from any sale of its interest in FoodsUp to a third party or an indirect or tracking ownership interest in FoodsUp in each case, as of to-be-determined record date (the “FoodsUp Divestment”). The FoodsUp Divestment, if it occurs, will mark an important step in the formal separation between the business of FoodsUp and Argo.

Q3 2024 Results Compared to Q3 2023

For the three months ended September 30

2024

2023

REVENUE

$449,567

$101,851

Cost of revenue

29,519

59,676

General and administration

1,019,001

377,350

Operational support

520,911

274,024

Research and development

614,149

122,573

Sales and marketing

73,054

73,068

Amortization

37,108

196,865

Depreciation

10,941

84,831

Total operating expenses

2,304,683

1,188,387

OPERATING LOSS

($1,855,166)

($1,086,536)

OTHER INCOME (EXPENSES)

Foreign exchange gain/ (loss)

(28,460)

(93,854)

Interest expenses

(532,931)

(61,018)

Interest income

1,023

272

Gain/ (Loss) on accounts payable settlements

301,483

Gain/ (Loss) on termination

279,606

Write down of intangible asset

(211,182)

Other income/(loss) from discontinued operations

(10,285,769)

(115,015)

Penalties and settlement

(68,500)

Share of loss of an associate

(593,014)

(2,860,412)

Net income/ (loss) from continuing operations

($12,992,860)

($4,216,563)

Discontinued Operations

Net income/ (loss) from discontinued operations

12,296,195

(1,037,987)

NET GAIN (LOSS)

($696,665)

($5,254,550)

Cumulative translation adjustment

(174,518)

(253,879)

NET PROFIT (LOSS)  AND COMPREHENSIVE PROFIT (LOSS)

($871,183)

($5,508,429)

(Loss) profit per share

– Basic and diluted

($0.01)

($0.04)

Weighted average shares outstanding – Basic and diluted

133,367,099

132,944,615

1 All figures are accurate to the hundreds.

In this press release, all references to ‘$’ are to Canadian dollars.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Argo

Argo delivers the first-ever vertically and publicly integrated city transit system. It is designed to augment public transportation and create a network of intelligently routed vehicles that work together to serve and scale to the needs of entire cities, putting people in control of their mobility. You can learn more at www.rideargo.com.

Praveen Arichandran, Co-CEO
Argo Corporation
(800) 575-7051

Forward-Looking Information

This news release includes certain forward-looking statements as well as management’s objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate,” “estimate,” and “intend,” and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, as described in more detail in the Company’s securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. See “Forward-Looking Information” and “Risk Factors” in the Company’s Annual Management Discussion & Analysis (MD&A) for the year ended December 31, 2023 (filed on SEDAR+ on May 8, 2024) and its interim MD&A for the periods ended September 30, 2023, March 31, 2024, June 30, 2024, and September 30, 2024 for a discussion of the uncertainties, risks and assumptions associated with these statements and other risks. Readers are urged to consider the uncertainties, risks, and assumptions carefully when evaluating forward-looking information and are cautioned not to place undue reliance on such information. We have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities legislation and regulatory requirements.

SOURCE ARGO CORPORATION

Continue Reading

Technology

Hippo Pharmacy Unveils Redesigned Website to Enhance Affordable Access to Prescription Medications

Published

on

By

Hippo Pharmacy has launched a redesigned website to make purchasing prescription medications like Ozempic, Mounjaro, Wegovy, and Rybelsus from Canada more affordable and convenient for U.S. patients. The updated platform offers a seamless, secure experience, allowing customers to save significantly while accessing high-quality, FDA-approved treatments.

TORONTO, Nov. 29, 2024 /PRNewswire-PRWeb/ — Hippo Pharmacy, a trusted online prescription referral service, is thrilled to announce the launch of its newly redesigned website, http://www.hippopharmacy.com. This fresh, user-friendly platform reaffirms Hippo Pharmacy’s commitment to making high-quality prescription medications like Ozempic, Mounjaro, Wegovy, Rybelsus, and more affordable and accessible to patients in the United States.

A Seamless Online Experience

The revamped website offers an intuitive navigation system, enhanced security features, and comprehensive resources to guide users through purchasing medications online. Designed with customer convenience in mind, the updated platform simplifies the process of obtaining prescription medications from Canada—a cost-effective and reliable alternative to the high prices often encountered in the U.S.

Affordable Medications for Life-Changing Treatments

As medication costs in the U.S. continue to rise, many Americans face challenges in accessing essential treatments. Hippo Pharmacy bridges this gap by providing affordable access to FDA-approved medications, including popular prescriptions for weight management and chronic conditions like semaglutide-based treatments (Ozempic, Wegovy, Rybelsus) and other innovative therapies such as Mounjaro. With savings of up to 80% compared to U.S. prices, Hippo Pharmacy empowers patients to prioritize their health without financial strain.

Why Choose Hippo Pharmacy?

Affordable Prices: By sourcing from certified Canadian pharmacies, Hippo Pharmacy ensures cost-effective options for life-changing medications.Safety and Quality Assurance: Every prescription undergoes rigorous verification by licensed pharmacists to maintain the highest safety standards.Efficient Delivery: Medications are securely packaged and promptly shipped to the U.S., ensuring safe and timely arrival.Expert Support: Customers benefit from a knowledgeable and courteous support team ready to assist at every step.

A Message from Hippo Pharmacy

“We’re excited to launch our redesigned website, which represents our ongoing commitment to helping patients access the medications they need safely, affordably, and efficiently,” said Mark Takla, Founder of Hippo Pharmacy. “This is more than a website update—it’s a step forward in our mission to revolutionize how Americans access affordable healthcare solutions.”

Join the Healthcare Revolution

Explore the new website at http://www.hippopharmacy.com to experience affordable, high-quality healthcare from Canada. From seamless ordering to secure delivery, Hippo Pharmacy continues to make safe, cost-effective treatments accessible to patients across the U.S.

About Hippo Pharmacy
Hippo Pharmacy is a leading online prescription referral service based in Central Canada. By partnering with certified Canadian pharmacies, Hippo Pharmacy offers patients in the U.S. access to high-quality, FDA-approved medications at significantly lower prices. With a focus on safety, affordability, and excellent customer service, Hippo Pharmacy is dedicated to transforming the healthcare experience.

Media Contact

Mark Takla, Hippo Pharmacy, +1-888-235-5810, info@hippopharmacy.com, https://hippopharmacy.com/

View original content to download multimedia:https://www.prweb.com/releases/hippo-pharmacy-unveils-redesigned-website-to-enhance-affordable-access-to-prescription-medications-302318978.html

SOURCE Hippo Pharmacy

Continue Reading

Technology

Argo Corporation Reports Third Quarter 2024 Financial Results

Published

on

By

TORONTO, Nov. 29, 2024 /CNW/ – Argo Corporation (TSXV: ARGH), (OTCQX: ARGHF) (“Argo” or the “Company”), a new venture delivering the first-ever vertically and publicly integrated city transit system, announced today its financial results for the quarter ended September 30, 2024 (“Q3 2024”). During the third quarter of 2024, Argo deployed its smart transit system with its first paying customers and made significant progress in restructuring prior initiatives in its publicly traded entity. 

Argo Highlights

Argo School: The Company successfully deployed its smart transit solution to a series of private schools in the Greater Toronto Area, providing end-to-end student transportation operations. Argo’s innovative technology delivers access to more flexibility and real-time tracking of students and vehicles, with unprecedented safety, reliability, and transparency for families and schools alike. The Company plans to continue to expand this solution to other private and public schools throughout Canada and abroad.Argo City: Argo’s public transit solution is the first to integrate custom software with vehicular hardware to create a network of intelligently routed vehicles that augment public transit systems with on-demand, door-to-door service. Argo City aims to reduce private car usage and increase ridership of existing public transit systems through partnership with cities, transit agencies, and governments. The Company expects to announce its first city partners in the coming months.R&D Investment: The Company’s quarterly R&D investment spend for Q3 2024 increased by 401% year-over-year. This investment reflects a significant focus on developing the Company’s proprietary vertically and publicly integrated city transit system, with significant progress in software and hardware functionality to enable seamless and reliable school and city deployments, putting people in control of their mobility.

Restructuring Updates

Vehicle Subscription: $8.5M in liabilities have been reclassified in Q3 2024 as held for sale as a result of wholly owned subsidiaries Steer EV Canada Inc. filing an assignment into bankruptcy under the Bankruptcy and Insolvency Act in Canada and Steer Holdings LLC, making a General Assignment for the Benefit of Creditors, pursuant to California law. The Company anticipates these liabilities will be removed in the coming quarters upon completing these legal processes, aligning with its restructuring efforts announced in the May 23, 2024, press release.Disputed Office Lease: Argo filed a statement of claim regarding a disputed office lease with landlord 8174709 Canada Inc. and the Company’s former CEO. The disputed lease represents $3.6M in liabilities and payables on the Company’s balance sheet.Sale of Financial Assets: The Company continues to engage in active sales processes for intellectual property and financial assets associated with the last venture in its publicly traded entity. In Q3 2024, the Company completed the sale of 14,200 shares of preferred stock in the capital of Westbrook Global Inc., receiving a cash payment of $750K as consideration.

FoodsUp Updates

Argo maintains a 59.95% non-controlling ownership interest in FoodsUp Inc. (“FoodsUp”), one of Canada’s leading restaurant supply platforms. In Q3 2024, FoodsUp had revenues of $28.7M, representing a 10% increase over Q2 2024 and a 61% yearly increase in quarterly revenues from Q3 2023.

The Company remains committed to implementing a transaction structure, the effect of which would be to provide the shareholders of Argo with the net proceeds from any sale of its interest in FoodsUp to a third party or an indirect or tracking ownership interest in FoodsUp in each case, as of to-be-determined record date (the “FoodsUp Divestment”). The FoodsUp Divestment, if it occurs, will mark an important step in the formal separation between the business of FoodsUp and Argo.

Q3 2024 Results Compared to Q3 2023

For the three months ended September 30

2024

2023

REVENUE

$449,567

$101,851

Cost of revenue

29,519

59,676

General and administration

1,019,001

377,350

Operational support

520,911

274,024

Research and development

614,149

122,573

Sales and marketing

73,054

73,068

Amortization

37,108

196,865

Depreciation

10,941

84,831

Total operating expenses

2,304,683

1,188,387

OPERATING LOSS

($1,855,166)

($1,086,536)

OTHER INCOME (EXPENSES)

Foreign exchange gain/ (loss)

(28,460)

(93,854)

Interest expenses

(532,931)

(61,018)

Interest income

1,023

272

Gain/ (Loss) on accounts payable settlements

301,483

Gain/ (Loss) on termination

279,606

Write down of intangible asset

(211,182)

Other income/(loss) from discontinued operations

(10,285,769)

(115,015)

Penalties and settlement

(68,500)

Share of loss of an associate

(593,014)

(2,860,412)

Net income/ (loss) from continuing operations

($12,992,860)

($4,216,563)

Discontinued Operations

Net income/ (loss) from discontinued operations

12,296,195

(1,037,987)

NET GAIN (LOSS)

($696,665)

($5,254,550)

Cumulative translation adjustment

(174,518)

(253,879)

NET PROFIT (LOSS)  AND COMPREHENSIVE PROFIT (LOSS)

($871,183)

($5,508,429)

(Loss) profit per share

– Basic and diluted

($0.01)

($0.04)

Weighted average shares outstanding – Basic and diluted

133,367,099

132,944,615

1 All figures are accurate to the hundreds.

In this press release, all references to ‘$’ are to Canadian dollars.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Argo

Argo delivers the first-ever vertically and publicly integrated city transit system. It is designed to augment public transportation and create a network of intelligently routed vehicles that work together to serve and scale to the needs of entire cities, putting people in control of their mobility. You can learn more at www.rideargo.com.

Praveen Arichandran, Co-CEO
Argo Corporation
(800) 575-7051

Forward-Looking Information

This news release includes certain forward-looking statements as well as management’s objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate,” “estimate,” and “intend,” and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, as described in more detail in the Company’s securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. See “Forward-Looking Information” and “Risk Factors” in the Company’s Annual Management Discussion & Analysis (MD&A) for the year ended December 31, 2023 (filed on SEDAR+ on May 8, 2024) and its interim MD&A for the periods ended September 30, 2023, March 31, 2024, June 30, 2024, and September 30, 2024 for a discussion of the uncertainties, risks and assumptions associated with these statements and other risks. Readers are urged to consider the uncertainties, risks, and assumptions carefully when evaluating forward-looking information and are cautioned not to place undue reliance on such information. We have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities legislation and regulatory requirements.

SOURCE ARGO CORPORATION

Continue Reading

Trending